767 related articles for article (PubMed ID: 29753957)
1. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.
Alli S; Figueiredo CA; Golbourn B; Sabha N; Wu MY; Bondoc A; Luck A; Coluccia D; Maslink C; Smith C; Wurdak H; Hynynen K; O'Reilly M; Rutka JT
J Control Release; 2018 Jul; 281():29-41. PubMed ID: 29753957
[TBL] [Abstract][Full Text] [Related]
2. MRI-guided focused ultrasound enhances drug delivery in experimental diffuse intrinsic pontine glioma.
Ishida J; Alli S; Bondoc A; Golbourn B; Sabha N; Mikloska K; Krumholtz S; Srikanthan D; Fujita N; Luck A; Maslink C; Smith C; Hynynen K; Rutka J
J Control Release; 2021 Feb; 330():1034-1045. PubMed ID: 33188825
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
4. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
[TBL] [Abstract][Full Text] [Related]
5. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
[TBL] [Abstract][Full Text] [Related]
6. Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study.
Mainprize T; Lipsman N; Huang Y; Meng Y; Bethune A; Ironside S; Heyn C; Alkins R; Trudeau M; Sahgal A; Perry J; Hynynen K
Sci Rep; 2019 Jan; 9(1):321. PubMed ID: 30674905
[TBL] [Abstract][Full Text] [Related]
7. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
9. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound/Magnetic Targeting with SPIO-DOX-Microbubble Complex for Image-Guided Drug Delivery in Brain Tumors.
Fan CH; Cheng YH; Ting CY; Ho YJ; Hsu PH; Liu HL; Yeh CK
Theranostics; 2016; 6(10):1542-56. PubMed ID: 27446489
[TBL] [Abstract][Full Text] [Related]
11. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery.
Fan CH; Ting CY; Lin HJ; Wang CH; Liu HL; Yen TC; Yeh CK
Biomaterials; 2013 May; 34(14):3706-15. PubMed ID: 23433776
[TBL] [Abstract][Full Text] [Related]
12. Focused ultrasound mediated blood-brain barrier opening is safe and feasible in a murine pontine glioma model.
Englander ZK; Wei HJ; Pouliopoulos AN; Bendau E; Upadhyayula P; Jan CI; Spinazzi EF; Yoh N; Tazhibi M; McQuillan NM; Wang TJC; Bruce JN; Canoll P; Feldstein NA; Zacharoulis S; Konofagou EE; Wu CC
Sci Rep; 2021 Mar; 11(1):6521. PubMed ID: 33753753
[TBL] [Abstract][Full Text] [Related]
13. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.
Sun T; Zhang Y; Power C; Alexander PM; Sutton JT; Aryal M; Vykhodtseva N; Miller EL; McDannold NJ
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10281-E10290. PubMed ID: 29133392
[TBL] [Abstract][Full Text] [Related]
14. Technical Note: Quantification of blood-spinal cord barrier permeability after application of magnetic resonance-guided focused ultrasound in spinal cord injury.
Cross CG; Payne AH; Hawryluk GW; Haag-Roeger R; Cheeniyil R; Brady D; Odéen H; Minoshima S; Cross DJ; Anzai Y
Med Phys; 2021 Aug; 48(8):4395-4401. PubMed ID: 33999427
[TBL] [Abstract][Full Text] [Related]
15. An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain.
Jung B; Huh H; Lee EH; Han M; Park J
J Control Release; 2019 Dec; 315():55-64. PubMed ID: 31669208
[TBL] [Abstract][Full Text] [Related]
16. [Ultrasonic microbubbles for glioma-targeted drug delivery].
Chen LJ; Lu CT; Zhao YZ; Du LN; Jin YG
Yao Xue Xue Bao; 2015 Jan; 50(1):99-103. PubMed ID: 25924483
[TBL] [Abstract][Full Text] [Related]
17. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.
Treat LH; McDannold N; Zhang Y; Vykhodtseva N; Hynynen K
Ultrasound Med Biol; 2012 Oct; 38(10):1716-25. PubMed ID: 22818878
[TBL] [Abstract][Full Text] [Related]
18. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
19. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.
Park J; Zhang Y; Vykhodtseva N; Jolesz FA; McDannold NJ
J Control Release; 2012 Aug; 162(1):134-42. PubMed ID: 22709590
[TBL] [Abstract][Full Text] [Related]
20. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]